|
Claude H. Nash, PhD
Chief Executive Officer and Chairman
Paul J. Leibowitz, PhD
Chief Technology Officer and Director
Julian M.E. Lee, MA (Cantab), ACA
Chief Financial Officer and Director
Sandra Panem, PhD
Director
Robert J. Powell, Ph.D., MBA
Vice President, University Liaison
Eric R. Leibowitz, Esq.
In-House Counsel
Francis J. Bullock, PhD
Gerald Malone, MA, LLB
Seth A. Rudnick, MD
Natalie S. Rudolph, PhD
Bingham McCutchen LLP
US corporate counsel
Fasken Martineau LLP
UK corporate counsel
|
|
Sandra Panem, Ph.D. is a Managing Partner of Cross Atlantic Partners (CAP), a venture capital firm she joined in 2000. CAP actively manages private equity funds for investment in developing healthcare and life sciences companies in the United States. With more than $150-million under management, CAP focuses on later-stage private and public companies developing innovative drugs, devices, services, and outcome systems for human healthcare.
Previously, Dr. Panem was President of Vector Fund Management, where she was responsible for the start-up, capital raising, and management of the asset management affiliate of Vector Securities International. Operations included the management of the Vector Later-Stage Equity Fund, L.P., and Vector Later-Stage Equity Fund II, L.P., private partnerships committing $240-million to equity investments in the emerging life science and healthcare industries.
Prior to joining Vector, Dr. Panem served as Vice President and Portfolio Manager for the Oppenheimer Global BioTech Fund, a $200-million mutual fund that invested in public and private biotechnology companies. Prior to Oppenheimer, Dr. Panem was Vice President at Salomon Brothers, Inc. where she acted as a member of Salomon Brothers Venture Capital, a $40-million fund focused on early and later-stage life science and technology investments.
Dr. Panem was an Assistant Professor at the University of Chicago and a Fellow at the Brookings Institution, and is the author of several books and papers concerning the commercialization of new medical technologies. She is also a director of the Society for Women's Health Research and a director of the New York Biotechnology Association. She received a B.S. Degree in Biochemistry and a Ph.D. in Microbiology from the University of Chicago.
|
|
